Sinovac
-
Sinovac Files Clinical Trial Application for HFMD in China
Sinovac Biotech, a provider of biopharmaceutical products in China, has filed an application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes …
Sinovac | 07 January 2010
-
Sinovac Files Clinical Trial Application for HFMD in China
Siinovac Biotech, a provider of biopharmaceutical products in China, has filed the application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which caus…
Sinovac | 01 January 2010
-
Sinovac Obtains Production License for H1N1 Vaccine
Sinovac Biotech has announced that the State Food and Drug Administration (SFDA) has approved the registration application for Panflu.1, a H1N1 vaccine, and has issued a production license for this vaccine. Following results which showed that the …
Sinovac | 09 September 2009
-
Sinovac Announces $9.75 Million Private Placement
Sinovac Biotech Ltd., a leading provider of vaccines in China, said it entered into a securities purchase agreement in connection with a private placement to an institutional accredited investor and, subject to standard closing conditions, will recei…
Sinovac | 31 January 2008
-
Beijing Public Health Bureau Buys Sinovac's Seasonal Influenza Vaccine
The Beijing Public Health Bureau has entered into an agreement with Sinovac Biotech to purchase Anflu, a split influenza vaccine developed and manufactured by the company. This measure is undertaken to prevent and control infectious diseases, improve…
Sinovac | 01 November 2007
-
Sinovac Announces Phase I Trial Results of Pandemic Influenza Vaccine
Chinese-based Sinovac Biotec Ltd has announced phase I clinical trial results for pandemic influenza vaccine. The project is supported by the Ministry of Science and Technology of the People’s Republic of China and co-developed by the Chinese Cente…
Sinovac | 01 October 2006
